Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Cytune Pharma is developing a portfolio of immunotherapeutic agents to treat primarily cancer. Cytune's compound, CYP 0150, is a human interleukin-15 linked to its effector.
Company (Acquired)
Phone: +33 (0) 666 495 594
7 Rue Amedee Menard
Nantes, 44300
France
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Il-15 and il-15r\alpha sushi domain based immunocytokines | Jun 19, 2018 | Jan 26, 2021 | Patent |
Il-15/il-15ralpha based conjugates purification method | Mar 03, 2015 | Oct 20, 2020 | Patent |
Il-15 and il-15r\alpha sushi domain based immunocytokines | Jul 19, 2016 | Apr 21, 2020 | Patent |
Il-15/il-15ralpha based conjugates purification method | Sep 18, 2020 | Application | |
Il-15 and il-15raplha sushi domain based modulokines | Aug 08, 2014 | Application |